A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)

CDKN2A is the major melanoma susceptibility gene so far identified, but only 40% of three or more case families have identified mutations. A comparison of mutation detection rates was carried out by “blind” exchange of samples across GenoMEL, the Melanoma Genetics Consortium, to establish the false...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Harland, Mark, Goldstein, Alisa M, Kukalizch, Kairen, Taylor, Claire, Hogg, David, Puig, Susana, Badenas, Celia, Gruis, Nelleke, Huurne, Jeanet ter, Bergman, Wilma, Hayward, Nicholas K, Stark, Mitchell, Tsao, Hensin, Tucker, Margaret A., Landi, Maria Teresa, Scarra, Giovanna Bianchi, Ghiorzo, Paola, Kanetsky, Peter A., Elder, David, Mann, Graham J, Holland, Elizabeth A, Bishop, D Timothy, Bishop, Julia Newton
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2008
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2494985/
https://ncbi.nlm.nih.gov/pubmed/18394881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2008.03.005
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk